论文部分内容阅读
目的对儿童支原体肺炎的临床疗效进行探讨与分析。方法选自2011年1月~2012年6月我科收治支原体肺炎患儿98例,对其临床特点进行回顾性分析与评价。结果 98例患儿中,7~13岁的患儿占了50%以上,大多数患儿表现为持续发热且咳嗽。患儿MP-IgM阳性率较高,且多数患儿外周血白细胞总数正常。有患儿诊断出肺外合并症,少数患儿还伴有心肌酶增高。除此之外,患儿还伴有神经系统症状与肺外症状。本次实验所用药物为大环内酯类抗生素以及利福平等,疗效颇佳。结论对于儿童支原体肺炎患者,以7~13岁学龄儿童偏多,且患儿MP-IgM阳性率较高,对于此种疾病,应尽早治疗,否则,将导致肺炎与肺外系统损害的发生。
Objective To investigate and analyze the clinical efficacy of mycoplasma pneumonia in children. Methods From January 2011 to June 2012, 98 cases of mycoplasma pneumonia were treated in our department, and their clinical features were retrospectively analyzed and evaluated. Results Of the 98 children, 7 to 13 years old accounted for more than 50% of the children, most children showed persistent fever and cough. MP-IgM positive rate in children with high, and most children with normal total number of peripheral white blood cells. Children diagnosed with pulmonary complications, a small number of children also accompanied by increased myocardial enzymes. In addition, children with neurological symptoms and extra-pulmonary symptoms. The experimental drugs used macrolide antibiotics and rifampicin, the effect is quite good. Conclusions For children with mycoplasma pneumonia, there are more school-aged children aged 7-13 years and a higher positive rate of MP-IgM in children. Treatment of such diseases should be treated as soon as possible, otherwise, pneumonia and extra-pulmonary system damage will occur.